Eltrombopag/Eltrombopag price and purchase channels
Eltrombopag/Eltrombopag is one of several new drugs recently developed to treat patients with immune thrombocytopenia (ITP). Rather than preventing the destruction of platelets, these drugs increase platelet production, which may overwhelm the immune system and result in normal platelet counts in individuals who are refractory to or dependent on other therapies. These treatments were well tolerated, and randomized controlled trials showed improved platelet counts and reduced bleeding in refractory patients.
Eltrombopag is availableas 25 mg, 50 mg, or 75 mg tablets to be taken by mouth once daily. Because food and divalent cations can affect absorption, recipients should not eat 2 hours before or after taking eltrombopag and should not take medications containing divalent cations (such as antacids or calcium).

The original drug of Eltrombopag, namely Eltrombopag ethanolamine tablets, is available in the domestic market in two specifications: 25mg 14 tablets and 25mg 28 tablets, with prices ranging from 2,000 to 4,000 yuan. This drug has been included in Class B medical insurance, but reimbursement is limited to patients who meet the indications. Those who do not meet the requirements need to purchase it at their own expense. Patients in need can first obtain the prescription information issued by the doctor, and then purchase the medicine at a hospital or pharmacy.
In addition, the original drug Eltrombopag is also sold in Türkiye and India, and the price per box is about 1 more than 1,000 yuan, which is affected by the exchange rate. At the same time, there are also generic drugs available in overseas markets. Their ingredients are basically the same as the original drugs. For example, those produced by pharmaceutical factories such as Bangladesh Yaopin International, Laos Lucius Pharmaceuticals, and India NATCO are more affordable, with only a few hundred yuan per box. However, they are also affected by exchange rate fluctuations. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)